<?xml version='1.0' encoding='utf-8'?>
<record xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
			<header>
				<identifier>oai:aavptbiennial-ojs-tamu.tdl.org:article/181</identifier>
				<datestamp>2024-10-30T18:55:26Z</datestamp>
				<setSpec>aavptbiennial:S7</setSpec>
			</header>
			<metadata>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Newer Concepts in Gastrointestinal Therapeutics in Small Animals</dc:title>
	<dc:creator xml:lang="en">Tams, Todd R.</dc:creator>
	<dc:subject xml:lang="en">Gastrointestinal disorders</dc:subject>
	<dc:subject xml:lang="en">cat</dc:subject>
	<dc:subject xml:lang="en">dog</dc:subject>
	<dc:subject xml:lang="en">metoclopramide</dc:subject>
	<dc:subject xml:lang="en">cimetidine</dc:subject>
	<dc:description xml:lang="en">Gastrointestinal (GI) disorders are among the most common reasons that small animal patients are presented to veterinarians. As a result, a number of drugs have been made available for the treatment of gastrointestinal signs (vomiting, diarrhea, inappetance). Certain of these drugs are in combination preparations that, although they may alleviate the clinical signs of a GI problem, may not effect primary treatment for a particular disorder. Veterinary education should continue to stress the importance of pursuing a definitive diagnosis whenever possible as well as prescribing a specific treatment.
This paper discusses two of the newer drugs available for use in veterinary clinical practice for treatment of gastrointestinal disorders in dogs and cats. They are metoclopramide (Reglan®), a prokinetic agent, and cimetidine (Tagame®), an H₂ - receptor blocker. These drugs offer primary therapy for disorders that previously were difficult to treat effectively. Specific indications for their use are discussed.</dc:description>
	<dc:publisher xml:lang="en">AAVPT Biennial Symposia</dc:publisher>
	<dc:date>1984-04-25</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://aavptbiennial-ojs-tamu.tdl.org/aavptbiennial/article/view/181</dc:identifier>
	<dc:source xml:lang="en">AAVPT Biennial Symposia; Fourth Symposium; 204-212</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://aavptbiennial-ojs-tamu.tdl.org/aavptbiennial/article/view/181/173</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 1984 American Academy of Veterinary Pharmacology and Therapeutics</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		
